Abstract Background Mesenchymal stem cells (MSCs) are used for the treatment of
osteoarthritis (OA), and MSC genetic engineering is expected to enhance cartilage repair …

Background Recently, cell-based tissue engineering approaches using mesenchymal stem
cells (MSCs) have been used to treat osteoarthritis (OA). However, the efficacy of human …

Objective: In recent times, it has been recognized that mesenchymal stem cells (MSCs)
possess the capability to address osteoarthritis (OA). The objective of this research was to …

Osteoarthritis (OA) is a common disorder and the restoration of the diseased articular
cartilage in patients with OA is still a challenge for researchers and clinicians. Currently, a …

Mesenchymalstem cell (MSC)-based therapy is being increasingly explored in preclinical
and clinical studies as a regenerative method for treating osteoarthritis (OA). However, the …

Mesenchymal stem cells (MSCs) are known to have the potential for articular cartilage
regeneration, and are suggested for the treatment of osteoarthritis (OA). Here, we …

Osteoarthritis is a chronic degenerative joint disorder characterized by articular cartilage
destruction and osteophyte formation. Chondrocytes in the matrix have a relatively slow …

Mesenchymal stem cell (MSC)-based therapies may aid in the repair of articular cartilage
defects. The purpose of this study was to investigate the effects of intraarticular injection of …

Osteoarthritis (OA), one of the most common joint disease, affects more than 80% of the
population aged 70 or over. Mesenchymal stem cells (MSCs) show multi-potent …

Of the many cell-based treatments that have been tested in an effort to regenerate
osteoarthritic articular cartilage, none have ever produced cartilage that compare with native …